- Home
- EXEL vs PAG Comparison
EXEL vs PAG Comparison
Compare EXEL & PAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | PAG |
|---|---|---|
| Founded | 1994 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 10.4B |
| IPO Year | 2000 | 1996 |
Fundamental Metrics
Financial Performance| Metric | EXEL | PAG |
|---|---|---|
| Price | $44.26 | $164.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 8 |
| Target Price | $45.45 | ★ $187.00 |
| AVG Volume (30 Days) | ★ 2.5M | 250.9K |
| Earning Date | 02-10-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 3.34% |
| EPS Growth | ★ 53.55 | 8.93 |
| EPS | 2.38 | ★ 14.20 |
| Revenue | $2,288,218,000.00 | ★ $30,682,000,000.00 |
| Revenue This Year | $9.79 | $1.93 |
| Revenue Next Year | $12.01 | $2.72 |
| P/E Ratio | $18.53 | ★ $11.65 |
| Revenue Growth | ★ 9.93 | 2.25 |
| 52 Week Low | $31.90 | $134.05 |
| 52 Week High | $49.62 | $189.51 |
Technical Indicators
Market Signals| Indicator | EXEL | PAG |
|---|---|---|
| Relative Strength Index (RSI) | 52.46 | 52.79 |
| Support Level | $43.28 | $160.40 |
| Resistance Level | $46.31 | $166.08 |
| Average True Range (ATR) | 1.44 | 3.33 |
| MACD | -0.10 | -0.11 |
| Stochastic Oscillator | 43.60 | 77.39 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About PAG Penske Automotive Group Inc.
Penske Automotive Group operates in 19 US states and overseas. It has over 150 US and Puerto Rico light-vehicle stores as well as 210 franchised dealerships overseas, primarily in the United Kingdom but also in Australia, Germany, Italy, and Japan. The company is the third-largest US publicly traded dealership in terms of light-vehicle revenue and sells more than 40 brands, with over 90% of retail automotive revenue coming from luxury and import names. Other segments are service and finance and insurance. The firm's Premier Truck Group owns 45 truck dealerships selling mostly Freightliner and Western Star brands, and Penske owns 16 used-vehicle stores, mostly in the US and UK under the CarShop (US) and Sytner Select (UK) brands. Penske is based in Bloomfield Hills, Michigan.